Related Experiment Video
Updated: Apr 22, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Evidence-based medicine and myocardial protection--where is the evidence?
Z G Ferguson1, D E Yarborough1, B L Jarvis1
1Medical University of South Carolina, Charleston, USA.
Insights
Current cardioplegic solutions lack robust human trials. More comparative research is needed to guide evidence-based selection beyond surgeon preference in cardiac surgery.
Area of Science:
- Cardiovascular Surgery
- Cardiothoracic Anesthesia
- Cardiac Anesthesia
Background:
- Cardioplegia is crucial for myocardial protection during cardiac surgery, limiting metabolic activity and enhancing ischemia tolerance.
- Despite its long history, debate persists regarding the optimal cardioplegic solution for cardiac surgical procedures.
- Current practices are influenced by surgeon preference due to a lack of definitive comparative research.
Purpose of the Study:
- To review current cardioplegia practices in cardiac surgery.
- To identify the paucity of high-quality human research supporting best practices in cardioplegia selection.
- To highlight the need for evidence-based medicine in choosing cardioplegic agents.
Main Methods:
- Systematic review of journal publications on commonly used cardioplegic solutions.
- Assessment of microplegia, del Nido, Custodiol HTK, and 4:1 blood cardioplegia.
- Evaluation of scientific validity, study design (retrospective vs. RCTs), and patient outcomes across different cardioplegia types.
Main Results:
- Limited randomized clinical trials exist comparing cardioplegic solutions in human subjects.
- Retrospective studies often report similar intraoperative and postoperative outcomes.
- Specific solutions like del Nido cardioplegia lack substantial human trial data, hindering evidence-based application.
Conclusions:
- Uniform study variables are needed for accurate systematic review and analysis of cardioplegia effectiveness.
- Multicenter data collection and comparative effectiveness studies are recommended to guide cardioplegia selection.
- Transitioning from surgeon preference to evidence-based medicine is essential for optimizing myocardial protection.
Objective:
Myocardial protection with cardioplegia is an integral component of most cardiac surgical procedures, providing protection of the heart by limiting metabolic activity and increasing the myocardium's capacity to withstand ischemia for prolonged periods of time. Cardioplegia has greatly affected the landscape of cardiothoracic surgery since its introduction in the 1960s, but, to this day, there continues to be a debate over what the ideal cardioplegic solution should be. The goal of this analysis is to describe current practices in cardioplegia and to point out the lack of quality human research and subsequent publications that prevent best practices from being utilized.
Methods:
This study is a systematic review of journal publications pertaining to the composition of commonly used cardioplegic solutions. Four main types of cardioplegia were assessed to give a narrower field of examination; specifically, microplegia, del Nido, Custodiol HTK, and 4:1 blood cardioplegia. Other combinations of cardioplegia, including St. Thomas's Solution and the University of Wisconsin (UW) Solution, were considered when applicable according to the context of the publication being reviewed. Factors being assessed consisted of scientific validity, nature of the test subject (isolated organ vs. animal vs. human studies), experimental setup (retrospective trials vs. randomized clinical trials) and patient outcomes.
Results:
There are very few randomized clinical trials with human subjects comparing commonly used cardioplegic solutions. Numerous retrospective studies exist, but often show similar intraoperative and postoperative outcomes between the solutions. Some solutions, del Nido cardioplegia in particular, were found to have few or no significant human trials to back the rigor required in such a highly specialized field as cardiovascular surgery. A wide variation in the types of surgeries and primary outcomes were included in the publications, so it is difficult to perform an accurate systematic review of the topic.
Conclusion:
Uniform variables among different studies would be preferable for analysis of this topic; thus, it is the researchers' recommendation that the collection of multicenter data be undertaken in order to more fully answer this research question.Comparative effectiveness studies to associate commonly used solutions are needed. Without this research, surgeon preference remains the primary determining factor for deciding which cardioplegic solution to use. Cardioplegia selection should rely more on higher scientific research, using evidenced-based medicine and ranking of clinical studies.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
10:05Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy II: Dilated Cardiomyopathy